Director Share Purchase

    RNS Number : 5666F
  Meldex International PLC
  10 October 2008
   

 For Immediate Release  10 October 2008


    Meldex International Plc ("Meldex " or "the Company")

    Director Share Purchase


    London, UK, 10 October 2008: Meldex (AIM: MDX), the specialty pharma and healthcare company announces that it has been informed that Dr
Jim Murray, Interim Executive Chairman, has purchased 65,000 shares.

    The shares were purchased in two tranches. 50,000 were bought at 17.5p on 9 October and the balance were bought today at 18p. This
brings Dr Murray's total holding in the Company to 93,500 ordinary shares, representing 0.04% of the issued ordinary share capital


    For further information:

    Buchanan Communications                     + 44 (0) 20 7466 5000
    Rebecca Skye Dietrich

    FinnCap, NOMAD                                      + 44 (0) 20 7600 1658
    Geoff Nash




    About Meldex International Plc
    Meldex International plc is an innovative specialty pharmaceutical and OTC product Company. Listed on London's AIM in May 2003, the
Company has over 80 patents granted or in application within 24 patent families and has product development agreements and strategic
alliances with several global healthcare companies. Meldex has acquired sales and marketing resources within Europe and the US as a launch
mechanism for its own pharmaceutical products. Meldex acquired the Melbrosin business in June 2007. Melbrosin's focus is on consumer over
the counter health care products based on substances of natural and plant origin which are developed into consumer orientated brands then
scaled, produced and distributed by Melbrosin. The Melbrosin complements the prescription pharmaceutical sales and marketing business
created and expanded in 2006.

    The business continues to develop innovative delivery mechanisms enhancing both its own product range and those of selected partners
using its proprietary XGELTM polymer technology. For further information please go to www.meldexinternational.com



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
RDSFFMSUSSASEES